The dangers of growing DNA databases
By Osagie K. Obasogie,
Los Angeles Times
| 04. 09. 2010
President Obama may have given credence to a relatively new but questionable law enforcement practice that the rest of the developed world is starting to shun: taking and retaining DNA samples from individuals arrested for a crime but not convicted. That is, putting innocent people's DNA in criminal databases.
During an interview with the president last month on the television program "America's Most Wanted," host John Walsh enthusiastically supported the expansion of this practice in the United States, saying, "We now have 18 states who are taking DNA upon arrest. England has done it for years. It's no different than fingerprinting or a booking photo." To which President Obama said, "It's the right thing to do."
But many in the human rights community disagree. For example, the European Court of Human Rights unanimously ruled in 2008 that the United Kingdom's policy of keeping arrestees' genetic samples after their release -- the very practice that Walsh (and by implication Obama) endorses -- violates a right respecting private and family life codified by the European Convention on Human Rights. At the time...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...